Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Zomedica Corp. ZOM

Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. The company is currently focused on the final development and commercialization of its TRUFORMA platform, which detects thyroid disorders in dogs & cats and adrenal disorders in dogs. Its operations are comprised of two reportable segments: Diagnostic & Therapeutics. It earns the majority of revenue from the therapeutics segment.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 

New Press Release - Zomedica Acquires Assets of Leading tPEM(TM) Company Assisi Animal Health

ANN ARBOR, MI / ACCESSWIRE / July 18, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion animals, today announced that it had acquired substantially all the assets of Assisi Animal Health...read article.

FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent

   rate and reply

Cloud DX and CBI Health Partnership Delivering Complex Care at Home

Partnership between Cloud DX remote monitoring and CBI Health at-home care present a Canadian first for hospital at home (H-a-H) use cases. Continuity of care enables patients to be discharged earlier and maintains safe, high quality, reliable care at home. Initial contract will augment and improve care for Cloud DX customer and partner Equitable Life of Canada. ...read more

New Press Release - Zomedica Announces New Global Manufacturing & Distribution Center

ANN ARBOR, MI / ACCESSWIRE / July 7, 2022/ Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion animals, is expanding its manufacturing and distribution facility in Roswell Georgia, which will...read article.

New Press Release - Zomedica Finalizes Acquisition of Veterinary Imaging Company Revo Squared

ANN ARBOR, MI / ACCESSWIRE / July 6, 2022 / Zomedica Corp. (NYSE American:ZOM) ('Zomedica' or the 'Company'), a veterinary health company offering diagnostic and therapeutic products for companion animals, today announced that the acquisition of the assets of Revo Squared LLC ('Revo') was...read article.

New Press Release - Zomedica Announces Designation of PulseVet(R) System as the Official Shock Wave Therapy Supplier of the United States Equestrian Team

ANN ARBOR, MI / ACCESSWIRE / June 28, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for equine and companion animals, is honored to announce that the United States Equestrian Federation (USEF) has...read article.

New Press Release - Zomedica to Participate in Panel Discussion at Animal Health Investment Forum

ANN ARBOR, MI / ACCESSWIRE / June 21, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion animals, announced today that Greg Blair, Zomedica's Vice President of Business Development...read article.

New Press Release - Zomedica to Acquire Assets of Innovative Veterinary Imaging Company Revo Squared

ANN ARBOR, MI / ACCESSWIRE / June 15, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion animals, today announced it has signed a definitive agreement to acquire substantially all of the...read article.

New Press Release - Zomedica to Investigate Shock Wave Therapy of Exercised Induced Pulmonary Hemorrhage in Horses

ANN ARBOR, MI / ACCESSWIRE / June 13, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion animals, has initiated a study to evaluate shock wave therapy as a treatment for Exercised Induced...read article.

Thematica Insights Report & Investor Guide

Winter is coming – investing in a recession

An investor's guide to understanding investment opportunities ahead of a recession. Click here to access the report.

New Press Release - Zomedica to Present at JMP Securities Life Sciences Conference

ANN ARBOR, MI / ACCESSWIRE / June 8, 2022 /Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, is pleased to announce today that Larry Heaton, Zomedica's Chief Executive...read article.

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

FSD Pharma ready to proceed with Phase 2 clinical trial of...read more

New Press Release - Karen DeHaan-Fullerton Joins Zomedica as General Counsel and Corporate Secretary

ANN ARBOR, MI / ACCESSWIRE / June 2, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, announced that it has appointed Karen DeHaan-Fullerton as its General Counsel...read article.

FSD Pharma Files Investigational New Drug Application “IND”

  rate and reply

New Press Release - Zomedica Enters Into Strategic Investment and Potential Collaboration for VetGuardian Monitoring Product Line

ANN ARBOR, MI / ACCESSWIRE / May 19, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion animals, today announced that it has purchased a $1.0 million convertible note from Structured...read article.

check out nirvana life sciences

newly listed Canadian company $nirv listing on the u.s OTC soon!  rate and reply

the discord

https://discord.gg/D9m7Se59  rate and reply

FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets

   rate and reply

Lucid-MS for Multiple Sclerosis Treatment

  rate and reply

"Julia Levy Award" Recipient David Allan and Dr. John McGraw

   rate and reply

FSD Pharma Inc: Lucid MS Video

FSD Pharma is delighted to announce pre-clinical findings...read more

FSD: Cancellation of Certain Shares Issued to Former CEO

FSD Pharma Announces Cancellation of Certain Shares Issued to Former Chief Executive Officer Dr. Raza Bokhari   TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A)...read more